IgA肾病的治疗新进展

New Progress in the Treatment of IgA Nephropathy

IgA肾病(IgA Nephropathy, IgAN)是全世界最常见的肾小球肾炎,临床和病理表现均有较高的异质性,其确切的发病机制迄今仍不明确。IgAN的治疗方案相对保守,需要探索的问题依然较多。随着相关研究的深入,生物靶向药物等的出现,给本病的治疗带来了更多的进步,本文就目前IgAN治疗的研究进展综述如下。

IgA nephropathy (IgAN) is the most common glomerulonephritis in the world. Its exact pathogene-sis is still unclear, and its clinical and pathological manifestations are highly heterogeneous. The treatment of IgAN is still relatively conservative. With the deepening of relevant research and the emergence of bio-targeted drugs, which have brought more benefits to patients, this article sum-marizes the current research progress of IgAN treatment as follows.